Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Chimeric Therapeutics Ltd. reported a late lodgement of Form 604 due to changes in substantial holdings caused by share dilution. The company stressed this as an isolated incident and assured its compliance with ASX regulations, while considering improved compliance monitoring. Investors might see this as a crucial step in maintaining transparency and regulatory adherence.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.